1.Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis
Gwang Ha KIM ; Myung-Gyu CHOI ; Jin Il KIM ; Soo Teik LEE ; Hoon Jai CHUN ; Kook Lae LEE ; Suk Chei CHOI ; Jae-Young JANG ; Yong Chan LEE ; Jae Gyu KIM ; Ki Bae KIM ; Ki-Nam SHIM ; Chong Il SOHN ; Sung Kook KIM ; Sang Gyun KIM ; Jin Seok JANG ; Nayoung KIM ; Hwoon-Yong JUNG ; Hyojin PARK ; Kyu Chan HUH ; Kwang Jae LEE ; Su Jin HONG ; Song BAEK ; Jin Joo HAN ; Oh Young LEE
Gut and Liver 2023;17(6):884-893
		                        		
		                        			 Background/Aims:
		                        			Fexuprazan is a novel potassium-competitive acid blocker that could be of benefit to patients with gastric mucosal injury. The aim of this study was to assess the 2-week efficacy and safety of fexuprazan in patients with acute or chronic gastritis. 
		                        		
		                        			Methods:
		                        			In this study, 327 patients with acute or chronic gastritis who had one or more gastric erosions on endoscopy and subjective symptoms were randomized into three groups receiving fexuprazan 20 mg once a day (q.d.), fexuprazan 10 mg twice a day (b.i.d.), or placebo for 2 weeks. The posttreatment assessments were the primary endpoint (erosion improvement rate), secondary endpoints (cure rates of erosion and edema and improvement rates of redness, hemorrhage, and subjective symptoms), and drug-related adverse events. 
		                        		
		                        			Results:
		                        			Among the patients, 57.8% (59/102), 65.7% (67/102), and 40.6% (39/96) showed erosion improvement 2 weeks after receiving fexuprazan 20 mg q.d., fexuprazan 10 mg b.i.d., and placebo, respectively. Both fexuprazan 20 mg q.d. and 10 mg b.i.d. showed superior efficacy to the placebo (p=0.017 and p<0.001, respectively). Likewise, both fexuprazan 20 mg q.d. and 10 mg b.i.d. also showed higher erosion healing rates than the placebo (p=0.033 and p=0.010, respectively). No difference was noted in the edema healing rate and the improvement rates for redness, hemorrhage, and subjective symptoms between the fexuprazan and placebo groups.No significant difference was noted in the incidence of adverse drug reactions. 
		                        		
		                        			Conclusions
		                        			Fexuprazan 20 mg q.d. and 10 mg b.i.d. for 2 weeks showed therapeutic efficacy superior to that of placebo in patients with acute or chronic gastritis (ClinicalTrials.gov identifier NCT04341454). 
		                        		
		                        		
		                        		
		                        	
2.Impact of carotid atherosclerosis in CHA2DS2-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation
Dong-Hyuk CHO ; Jong-Il CHOI ; Jimi CHOI ; Yun Gi KIM ; Suk-Kyu OH ; Hyungdon KOOK ; Kwang No LEE ; Jaemin SHIM ; Seong-Mi PARK ; Wan Joo SHIM ; Young-Hoon KIM
The Korean Journal of Internal Medicine 2021;36(2):342-351
		                        		
		                        			 Background/Aims:
		                        			Vascular disease is an established risk factor for stroke in patients with atrial fibrillation (AF), which is included in CHA2DS2-VASc score. However, the role of carotid atherosclerosis remains to be determined. 
		                        		
		                        			Methods:
		                        			Three hundred-ten patients with AF who underwent carotid sonography were enrolled. 
		                        		
		                        			Results:
		                        			During a median follow-up of 31 months, 18 events (5.8%) of stroke were identified. Patients with stroke had higher carotid intima-media thickness (CIMT) (1.16 ± 0.33 mm vs. 0.98 ± 0.25 mm, p = 0.017). CIMT was significantly increased according to the CHA2DS2-VASc score (p < 0.001) and it was correlated with left ventricular mass index and early diastolic mitral annular velocity (e’), a ratio of early transmitral flow velocity to e’ (E/e’) and pulmonary artery systolic pressure (all p < 0.05). Cox regression using multivariate models showed that carotid plaque was associated with the risk of stroke (hazard ratio, 3.748; 95% confidence interval [CI], 1.107 to 12.688; p = 0.034). C-statistics increased from 0.648 (95% CI, 0.538 to 0.757) to 0.716 (95% CI, 0.628 to 0.804) in the CHA2DS2-VASc score model after the addition of CIMT and carotid plaque as a vascular component (p = 0.013). 
		                        		
		                        			Conclusions
		                        			Increased CIMT and presence of carotid plaque are associated with a high risk of ischemic stroke, and CIMT is related to myocardial remodeling and diastolic dysfunction, suggesting that carotid atherosclerosis can improve risk prediction of stroke in patients with AF, when included under vascular disease in the CHA2DS2-VASc scoring system. 
		                        		
		                        		
		                        		
		                        	
3.Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children's immunity
Ko Eun LEE ; Sung Ae JUNG ; Sang Hyoung PARK ; Chang Mo MOON ; So Yeon SHIM ; Eun Soo KIM ; Su Jin CHO ; Seong Eun KIM ; Kwang Bum CHO ; Suk Kyun YANG
Intestinal Research 2019;17(2):237-243
		                        		
		                        			
		                        			BACKGROUND/AIMS: The onset of inflammatory bowel disease (IBD) usually occurs at young age, and therefore, women IBD patients experience pregnancy during their disease progression. Recently, the use of anti-tumor necrosis factor-α (anti-TNF-α) has been rapidly increasing. The aim of this study was to evaluate pregnancy related outcomes in women with IBD who were treated with anti-TNF-α during pregnancy and immunity of their children. METHODS: Korean women with IBD who had been treated with anti-TNF-α during pregnancy had been enrolled. Medical records were reviewed and a survey was performed for each patient. For the patients who agreed on additional examination for their children, children's growth, medical history and antibody to hepatitis B surface antigen (anti-HBs) titer were checked. RESULTS: All 18 patients had been diagnosed with Crohn's disease. There was not any case of preterm delivery, low birth-weight infant, congenital anomaly, nor stillbirth. All 12 children had followed the regular vaccination schedule for hepatitis B and 4 of them showed negative results for anti-HBs. After the 1 booster vaccination, all children demonstrated seroconversion. Regarding live vaccines, 4 children had bacillus Calmette-Guerin and 4 had rotavirus vaccine before 6 months, without any specific side effects. CONCLUSIONS: This was the first study of immunity of the children born from IBD women who had been treated with anti-TNF-α medication during their pregnancy. IBD women had comparable pregnancy outcomes with the general women population, suggesting that the disease activity rather than the administered medication would be more important in healthy pregnancy. Considering the history of vaccination and anti-HBs titers, immunity seems to be intact in the children.
		                        		
		                        		
		                        		
		                        			Appointments and Schedules
		                        			;
		                        		
		                        			Bacillus
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Crohn Disease
		                        			;
		                        		
		                        			Disease Progression
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hepatitis B
		                        			;
		                        		
		                        			Hepatitis B Surface Antigens
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Inflammatory Bowel Diseases
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Necrosis
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Pregnancy Outcome
		                        			;
		                        		
		                        			Rotavirus
		                        			;
		                        		
		                        			Seroconversion
		                        			;
		                        		
		                        			Stillbirth
		                        			;
		                        		
		                        			Vaccination
		                        			;
		                        		
		                        			Vaccines
		                        			
		                        		
		                        	
4.Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
Se Hoon LEE ; Boram LEE ; Joon Ho SHIM ; Kwang Woo LEE ; Jae Won YUN ; Sook Young KIM ; Tae You KIM ; Yeul Hong KIM ; Young Hyeh KO ; Hyun Cheol CHUNG ; Chang Sik YU ; Jeeyun LEE ; Sun Young RHA ; Tae Won KIM ; Kyung Hae JUNG ; Seock Ah IM ; Hyeong Gon MOON ; Sukki CHO ; Jin Hyoung KANG ; Jihun KIM ; Sang Kyum KIM ; Han Suk RYU ; Sang Yun HA ; Jong Il KIM ; Yeun Jun CHUNG ; Cheolmin KIM ; Hyung Lae KIM ; Woong Yang PARK ; Dong Young NOH ; Keunchil PARK
Cancer Research and Treatment 2019;51(1):211-222
		                        		
		                        			
		                        			PURPOSE: With the emergence of next-generation sequencing (NGS) technology, profiling a wide range of genomic alterations has become a possibility resulting in improved implementation of targeted cancer therapy. In Asian populations, the prevalence and spectrum of clinically actionable genetic alterations has not yet been determined because of a lack of studies examining high-throughput cancer genomic data. MATERIALS AND METHODS: To address this issue, 1,071 tumor samples were collected from five major cancer institutes in Korea and analyzed using targeted NGS at a centralized laboratory. Samples were either fresh frozen or formalin-fixed, paraffin embedded (FFPE) and the quality and yield of extracted genomic DNA was assessed. In order to estimate the effect of sample condition on the quality of sequencing results, tissue preparation method, specimen type (resected or biopsied) and tissue storage time were compared. RESULTS: We detected 7,360 non-synonymous point mutations, 1,164 small insertions and deletions, 3,173 copy number alterations, and 462 structural variants. Fifty-four percent of tumors had one or more clinically relevant genetic mutation. The distribution of actionable variants was variable among different genes. Fresh frozen tissues, surgically resected specimens, and recently obtained specimens generated superior sequencing results over FFPE tissues, biopsied specimens, and tissues with long storage duration. CONCLUSION: In order to overcome, challenges involved in bringing NGS testing into routine clinical use, a centralized laboratory model was designed that could improve the NGS workflows, provide appropriate turnaround times and control costs with goal of enabling precision medicine.
		                        		
		                        		
		                        		
		                        			Academies and Institutes
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			DNA
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Paraffin
		                        			;
		                        		
		                        			Point Mutation
		                        			;
		                        		
		                        			Precision Medicine
		                        			;
		                        		
		                        			Prevalence
		                        			
		                        		
		                        	
5.Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in Korea
Mun Su CHUNG ; Myungsun SHIM ; Jin Seon CHO ; Woojin BANG ; Sun Il KIM ; Sung Yong CHO ; Koon Ho RHA ; Sung Joon HONG ; Kyo Chul KOO ; Kwang Suk LEE ; Byung Ha CHUNG ; Seung Hwan LEE
Journal of Korean Medical Science 2019;34(10):e78-
		                        		
		                        			
		                        			BACKGROUND: Recently, younger prostate cancer (PCa) patients have been reported to harbour more favourable disease characteristics after radical prostatectomy (RP) than older men. We analysed young men (< 50 years) with PCa among the Korean population, paying attention to pathological characteristics on RP specimen and biochemical recurrence (BCR). METHODS: The multi-centre, Severance Urological Oncology Group registry was utilized to identify 622 patients with clinically localized or locally advanced PCa, who were treated with RP between 2001 and 2017. Patients were dichotomized into two groups according to age (< 50-year-old [n = 75] and ≥ 50-year-old [n = 547]), and clinicopathological characteristics were analysed. Propensity score matching was used when assessing BCR between the two groups. RESULTS: Although biopsy Gleason score (GS) was lower in younger patients (P = 0.033), distribution of pathologic GS was similar between the two groups (13.3% vs. 13.9% for GS ≥ 8, P = 0.191). There was no significant difference in pathologic T stage between the < 50- and ≥ 50-year-old groups (69.3% vs. 68.0% in T2 and 30.7% vs. 32.0% in ≥ T3, P = 0.203). The positive surgical margin rates were similar between the two groups (20.0% vs. 27.6%, P = 0.178). BCR-free survival rates were also similar (P = 0.644) between the two groups, after propensity matching. CONCLUSION: Contrary to prior reports, younger PCa patients did not have more favourable pathologic features on RP specimen and showed similar BCR rates compared to older men. These findings should be considered when making treatment decisions for young Korean patients with PCa.
		                        		
		                        		
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Neoplasm Grading
		                        			;
		                        		
		                        			Passive Cutaneous Anaphylaxis
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Propensity Score
		                        			;
		                        		
		                        			Prostate
		                        			;
		                        		
		                        			Prostatectomy
		                        			;
		                        		
		                        			Prostatic Neoplasms
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Survival Rate
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
6.Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
Jihyun AN ; Kwang Sun LEE ; Kang Mo KIM ; Do Hyun PARK ; Sang Soo LEE ; Danbi LEE ; Ju Hyun SHIM ; Young Suk LIM ; Han Chu LEE ; Young Hwa CHUNG ; Yung Sang LEE
Clinical and Molecular Hepatology 2017;23(2):160-169
		                        		
		                        			
		                        			BACKGROUND/AIMS: Little is known about the treatment or outcomes of hepatocellular carcinoma (HCC) complicated with bile duct invasion. METHODS: A total of 247 consecutive HCC patients with bile duct invasion at initial diagnosis were retrospectively included. RESULTS: The majority of patients had Barcelona Clinic Liver Cancer (BCLC) stage C HCC (66.8%). Portal vein tumor thrombosis was present in 166 (67.2%) patients. Median survival was 4.1 months. Various modalities of treatment were initially employed including surgical resection (10.9%), repeated transarterial chemoembolization (TACE) (42.5%), and conservative management (42.9%). Among the patients with obstructive jaundice (n=88), successful biliary drainage was associated with better overall survival rate. Among the patients with BCLC stage C, overall survival differed depending on the initial treatment for HCC; surgical resection, TACE, systemic chemotherapy, and conservative management showed overall survival rates of 11.5, 6.0 ,2.4, and 1.6 months, respectively. After adjusting for confounders, surgical resection and repeated TACE were significant prognostic factors for HCC patients with bile duct invasion (hazard ratios 0.47 and 0.39, Ps <0.001, respectively). CONCLUSIONS: The survival of HCC patients with bile duct invasion at initial diagnosis is generally poor. However, aggressive treatments for HCC such as resection or biliary drainage may be beneficial therapeutic options for patients with preserved liver function.
		                        		
		                        		
		                        		
		                        			Bile Ducts*
		                        			;
		                        		
		                        			Bile*
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular*
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Drainage
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Jaundice, Obstructive
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Liver Neoplasms
		                        			;
		                        		
		                        			Portal Vein
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Survival Rate
		                        			;
		                        		
		                        			Thrombosis
		                        			
		                        		
		                        	
7.Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.
Maria LEE ; Chel Hun CHOI ; Yi Kyeong CHUN ; Yun Hwan KIM ; Kwang Beom LEE ; Shin Wha LEE ; Seung Hyuk SHIM ; Yong Jung SONG ; Ju Won ROH ; Suk Joon CHANG ; Jong Min LEE
Journal of Gynecologic Oncology 2017;28(1):e5-
		                        		
		                        			
		                        			The Surgery Treatment Modality Committee of the Korean Gynecologic Oncologic Group (KGOG) has determined to develop a surgical manual to facilitate clinical trials and to improve communication between investigators by standardizing and precisely describing operating procedures. The literature on anatomic terminology, identification of surgical components, and surgical techniques were reviewed and discussed in depth to develop a surgical manual for gynecologic oncology. The surgical procedures provided here represent the minimum requirements for participating in a clinical trial. These procedures should be described in the operation record form, and the pathologic findings obtained from the procedures should be recorded in the pathologic report form. Here, we focused on radical hysterectomy and lymphadenectomy, and we developed a KGOG classification for those conditions.
		                        		
		                        		
		                        		
		                        			Classification*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gynecologic Surgical Procedures
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hysterectomy*
		                        			;
		                        		
		                        			Lymph Node Excision*
		                        			;
		                        		
		                        			Manuals as Topic
		                        			;
		                        		
		                        			Research Personnel
		                        			
		                        		
		                        	
8.Myofascial pain syndrome of gluteus minimus mimicking lumbar radiculitis: A case report.
Joong Ho PARK ; Kwang Suk SHIM ; Young Min SHIN ; Chiu LEE ; Sang Gon LEE ; Eun Ju KIM
Anesthesia and Pain Medicine 2015;10(1):16-20
		                        		
		                        			
		                        			Myofascial pain syndrome (MPS) can be characterized by pain caused by trigger points (TrPs) and fascial constrictions. Patients with MPS of the gluteus minimus muscles often complain of symptoms such as hip pain, especially when standing up after sitting or lying on the affected side, limping, and pain radiating down to the lower extremities. A 24-year-old female patient presenting with motor and sensory impairments of both lower extremities was referred to our pain clinic after initially being diagnosed with lumbar radiculitis. Under the impression of MPS of the gluteus minimus muscles following through evaluation and physical examination of the patient, we performed trigger point injections under ultrasonography guidance on the myofascial TrPs. Dramatic improvement of the patient's symptoms was observed following this treatment, and she was discharged without any further remaining symptoms.
		                        		
		                        		
		                        		
		                        			Constriction
		                        			;
		                        		
		                        			Deception
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hip
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lower Extremity
		                        			;
		                        		
		                        			Muscles
		                        			;
		                        		
		                        			Myofascial Pain Syndromes*
		                        			;
		                        		
		                        			Pain Clinics
		                        			;
		                        		
		                        			Physical Examination
		                        			;
		                        		
		                        			Radiculopathy*
		                        			;
		                        		
		                        			Trigger Points
		                        			;
		                        		
		                        			Ultrasonography
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
9.Ultrasound-guided infraorbital alcohol neurolysis for intractable trigeminal neuralgia: A case report.
Kyung Yoon WOO ; Kwang Suk SHIM ; Eun Ju KIM ; Ji Hyang LEE ; Sang Gon LEE ; Jong Seouk BAN
Anesthesia and Pain Medicine 2014;9(2):98-102
		                        		
		                        			
		                        			Trigeminal neuralgia is a severe pain disorder characterized by recurrent paroxysms of unilateral facial pain that is typically lancinating or stabbing, and is activated by cutaneous stimulation. Trigeminal alcohol neurolysis is an accepted treatment for trigeminal neuralgia. However, injections of alcohol must be placed accurately because alcohol is highly toxic. In this study, infraorbital alcohol neurolysises were performed under an ultrasound guidance. Ultrasound imaging is a safe, simple and non-invasive modality. This imaging tool allows fine adjustment of the needle tip and direct observation of the injectate. Two patients suffering from trigeminal neuralgia were treated with ultrasound-guided trigeminal alcohol neurolysis. They showed favorable pain relief without any serious complications over the 5- and 7-month follow-up, respectively.
		                        		
		                        		
		                        		
		                        			Facial Pain
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Needles
		                        			;
		                        		
		                        			Nerve Block
		                        			;
		                        		
		                        			Somatoform Disorders
		                        			;
		                        		
		                        			Trigeminal Neuralgia*
		                        			;
		                        		
		                        			Ultrasonography
		                        			
		                        		
		                        	
10.Usefulness of additional polarized light irradiation for those treated with stellate ganglion block in sudden deafness.
Joon Ho LEE ; Kwang Suk SHIM ; Da Mi SEO ; Eun Ju KIM ; Ji Hyang LEE ; Sang Gon LEE
Anesthesia and Pain Medicine 2013;8(1):9-12
		                        		
		                        			
		                        			BACKGROUND: Both stellate ganglion block (SGB) and polarized light irradiation (Superlizer) have a tendency to increase blood flow. Increases in blood flow can be estimated indirectly by changes in tympanic membrane temperature. In this study, we sought to evaluate how simultaneous SGB and Superlizer treatment affects tympanic temperature and tympanic blood flow in individuals suffering from sudden deafness. METHODS: Among patients who visited the pain clinic complaining of sudden deafness, we divided them into two groups: one receiving only SGB; the other receiving both SGB and Superlizer treatment. By comparing the tympanic membrane temperature measurements of both groups on 10, 30, and 60 minutes after treatment through a prospective study, we intended to evaluate the effect of treatment with SGB and Superlizer. RESULTS: Temperature changes measured after the injection were statistically significant in both groups. Temperature changes of the tympanic membrane were greater in the group who received both SGB and Superlizer compared to the group receiving only SGB. CONCLUSIONS: The results suggest that SGB followed by Superlizer has effects on the amount of increase in tympanic membrane temperature. This seems to be attributed to the increase in blood circulation of the inner ear compared with the group receiving only SGB. We came to the conclusion that in sudden deafness patients, the use of SGB combined with polarized light irradiation appears to be more effective in the treatment of sudden deafness.
		                        		
		                        		
		                        		
		                        			Blood Circulation
		                        			;
		                        		
		                        			Ear, Inner
		                        			;
		                        		
		                        			Hearing Loss, Sudden
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Light
		                        			;
		                        		
		                        			Pain Clinics
		                        			;
		                        		
		                        			Porphyrins
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Stellate Ganglion
		                        			;
		                        		
		                        			Stress, Psychological
		                        			;
		                        		
		                        			Tympanic Membrane
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail